New York Life Investment Management LLC Purchases 659 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

New York Life Investment Management LLC raised its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 6.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,764 shares of the company’s stock after acquiring an additional 659 shares during the quarter. New York Life Investment Management LLC’s holdings in Acadia Healthcare were worth $837,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in ACHC. Sivik Global Healthcare LLC boosted its stake in Acadia Healthcare by 20.0% in the 4th quarter. Sivik Global Healthcare LLC now owns 90,000 shares of the company’s stock worth $6,998,000 after purchasing an additional 15,000 shares during the period. Retirement Systems of Alabama boosted its position in shares of Acadia Healthcare by 0.4% during the fourth quarter. Retirement Systems of Alabama now owns 115,496 shares of the company’s stock worth $8,981,000 after acquiring an additional 409 shares during the last quarter. Headlands Technologies LLC grew its stake in Acadia Healthcare by 422.3% during the fourth quarter. Headlands Technologies LLC now owns 1,828 shares of the company’s stock valued at $142,000 after acquiring an additional 1,478 shares in the last quarter. Truist Financial Corp increased its holdings in Acadia Healthcare by 2.4% in the 4th quarter. Truist Financial Corp now owns 48,880 shares of the company’s stock valued at $3,801,000 after acquiring an additional 1,154 shares during the last quarter. Finally, Yousif Capital Management LLC lifted its stake in Acadia Healthcare by 1.6% in the 4th quarter. Yousif Capital Management LLC now owns 44,284 shares of the company’s stock worth $3,444,000 after purchasing an additional 706 shares in the last quarter.

Insider Buying and Selling

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the business’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the completion of the transaction, the director now directly owns 46,074 shares in the company, valued at $3,934,258.86. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 2.00% of the stock is currently owned by company insiders.

Acadia Healthcare Price Performance

Shares of ACHC stock opened at $66.06 on Thursday. Acadia Healthcare Company, Inc. has a twelve month low of $64.74 and a twelve month high of $87.77. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.63. The stock has a fifty day simple moving average of $75.67 and a two-hundred day simple moving average of $77.32. The stock has a market capitalization of $6.13 billion, a price-to-earnings ratio of -471.86, a P/E/G ratio of 1.96 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Thursday, May 2nd. The company reported $0.84 EPS for the quarter, beating the consensus estimate of $0.80 by $0.04. The business had revenue of $768.10 million during the quarter, compared to analyst estimates of $779.20 million. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. The company’s quarterly revenue was up 9.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.75 EPS. On average, analysts predict that Acadia Healthcare Company, Inc. will post 3.56 EPS for the current fiscal year.

Analysts Set New Price Targets

ACHC has been the topic of several research reports. StockNews.com cut Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Friday, May 3rd. UBS Group upped their price objective on Acadia Healthcare from $88.00 to $102.00 and gave the stock a “buy” rating in a report on Wednesday, February 28th. Mizuho cut their target price on shares of Acadia Healthcare from $84.00 to $70.00 and set a “neutral” rating for the company in a report on Friday, May 3rd. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 price target on the stock in a research report on Thursday, April 25th. Finally, Barclays lowered their price objective on shares of Acadia Healthcare from $100.00 to $91.00 and set an “overweight” rating for the company in a research report on Thursday, May 2nd. One research analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $88.89.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.